Clinical Trial Update: Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480) [Phase 2]

View source ↗

Summary

This Phase 2 trial (P03480) evaluating anastrozole with lonafarnib versus placebo for advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Lonafarnib (lonafarnib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED